Cargando…

Identification of a nonsense mutation in TNNI3K associated with cardiac conduction disease

BACKGROUND: Cardiac conduction disease (CCD) is a common cardiovascular disease which can lead to life‐threatening conditions. The importance of heredity in CCD has been realized in recent years. Several causal genes have been found to be implicated in CCD such as SCN5A, TRPM4, SCN1B, TNNI3K, LMNA,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jiang, Liu, Da, Li, Muzheng, Wu, Keke, Liu, Na, Zhao, Chenyu, Shi, Xiaoliu, Liu, Qiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521241/ https://www.ncbi.nlm.nih.gov/pubmed/32529721 http://dx.doi.org/10.1002/jcla.23418

Ejemplares similares

A Novel Missense Mutation in TNNI3K Causes Recessively Inherited Cardiac Conduction Disease in a Consanguineous Pakistani Family
por: Ramzan, Shafaq, et al.
Publicado: (2021)

The Diverse Roles of TNNI3K in Cardiac Disease and Potential for Treatment
por: Pham, Caroline, et al.
Publicado: (2021)

TNNI3K is a novel mediator of myofilament function and phosphorylates cardiac troponin I
por: Wang, Hui, et al.
Publicado: (2013)

Dissection of a Quantitative Trait Locus for PR Interval Duration Identifies Tnni3k as a Novel Modulator of Cardiac Conduction
por: Lodder, Elisabeth M., et al.
Publicado: (2012)

TNNI1 Mutated in Autosomal Dominant Proximal Arthrogryposis
por: Nishimori, Yukako, et al.
Publicado: (2021)

TNNI3K, a Cardiac-Specific Kinase, Promotes Physiological Cardiac Hypertrophy in Transgenic Mice
por: Wang, Xiaojian, et al.
Publicado: (2013)

New Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I–Interacting Kinase (TNNi3K)
por: Asquith, Christopher R. M., et al.
Publicado: (2020)

Tnni3k Modifies Disease Progression in Murine Models of Cardiomyopathy
por: Wheeler, Ferrin C., et al.
Publicado: (2009)

Distal arthrogryposis with variable clinical expression caused by TNNI2 mutation
por: Čulić, Vida, et al.
Publicado: (2016)

Tnni3k alleles influence ventricular mononuclear diploid cardiomyocyte frequency
por: Gan, Peiheng, et al.
Publicado: (2019)

Pediatric restrictive cardiomyopathy due to a heterozygous mutation of the TNNI3 gene
por: Chen, Yan, et al.
Publicado: (2014)

A case report of recessive restrictive cardiomyopathy caused by a novel mutation in cardiac troponin I (TNNI3)
por: Pantou, Malena P., et al.
Publicado: (2019)

Expression Levels of the Tnni3k Gene in the Heart Are Highly Associated with Cardiac and Glucose Metabolism-Related Phenotypes and Functional Pathways
por: Gu, Qingqing, et al.
Publicado: (2023)

Identification of Chimeric RNAs in Pig Skeletal Muscle and Transcriptomic Analysis of Chimeric RNA TNNI2-ACTA1 V1
por: Liu, Dongyu, et al.
Publicado: (2021)

Genetic Burden of TNNI3K in Diagnostic Testing of Patients With Dilated Cardiomyopathy and Supraventricular Arrhythmias
por: Pham, Caroline, et al.
Publicado: (2023)

Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy
por: van den Wijngaard, A., et al.
Publicado: (2011)

Tnni1b-ECR183-d2, an 87 bp cardiac enhancer of zebrafish
por: Zhang, Yawen, et al.
Publicado: (2020)

Whole-Exome Sequencing Identifies a Novel Variant (c.1538T > C) of TNNI3K in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Xie, Ting, et al.
Publicado: (2022)

Diverse Phenotypic Expression of Cardiomyopathies in a Family with TNNI3 p.Arg145Trp Mutation
por: Hwang, Ji-won, et al.
Publicado: (2017)

Homozygous TNNI3 Mutations and Severe Early Onset Dilated Cardiomyopathy: Patient Report and Review of the Literature
por: Sorrentino, Ugo, et al.
Publicado: (2023)

A Gain-of-Function Mutation in Tnni2 Impeded Bone Development through Increasing Hif3a Expression in DA2B Mice
por: Zhu, Xiaoquan, et al.
Publicado: (2014)

Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying TNNI3 mutations
por: Zhao, Shane Rui, et al.
Publicado: (2021)

SYT8 promotes pancreatic cancer progression via the TNNI2/ERRα/SIRT1 signaling pathway
por: Fu, Zhiping, et al.
Publicado: (2021)

Whole exome sequencing identified a pathogenic nonsense mutation in LMNA in a family with a progressive cardiac conduction defect: A case report
por: Fan, Peng, et al.
Publicado: (2020)

Cardiac conduction defects and Brugada syndrome: A family with overlap syndrome carrying a nonsense SCN5A mutation()
por: Aoki, Hisaaki, et al.
Publicado: (2017)

HIRA Is Required for Heart Development and Directly Regulates Tnni2 and Tnnt3
por: Dilg, Daniel, et al.
Publicado: (2016)

Case Report: Three novel pathogenic ABCC2 mutations identified in two patients with Dubin–Johnson syndrome
por: Zhao, Chenyu, et al.
Publicado: (2022)

High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis
por: Li, Muzheng, et al.
Publicado: (2021)

Identification of a Novel Nonsense Mutation in POLH in a Chinese Pedigree with Xeroderma Pigmentosum, Variant Type
por: Liu, Xiaoyan, et al.
Publicado: (2013)

Chimeric RNA TNNI2-ACTA1-V1 Regulates Cell Proliferation by Regulating the Expression of NCOA3
por: Liu, Dongyu, et al.
Publicado: (2022)

Adenine phosphoribosyltransferase (APRT) deficiency: identification of a novel nonsense mutation
por: Valaperta, Rea, et al.
Publicado: (2014)

Identification of a novel RHO heterozygous nonsense mutation in a Chinese family with autosomal dominant retinitis pigmentosa
por: Liu, Wei, et al.
Publicado: (2021)

A real-world study on diagnosis and prognosis of light-chain cardiac amyloidosis in Southern China
por: Wu, Zhijian, et al.
Publicado: (2021)

Identification of a novel nonsense mutation in the UNC13D gene from a patient with hemophagocytic lymphohistiocytosis: a case report
por: Hu, Xijiang, et al.
Publicado: (2018)

Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy
por: Mouton, Jomien M, et al.
Publicado: (2015)

Identification of a novel homozygous nonsense mutation in EYS in a Chinese family with autosomal recessive retinitis pigmentosa
por: Huang, Yukan, et al.
Publicado: (2010)

Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases
por: Benhabiles, Hana, et al.
Publicado: (2017)

A TNNI2 variant c.525G>T causes distal arthrogryposis in a Chinese family
por: Li, Yue, et al.
Publicado: (2022)

Identification of a novel RPS26 nonsense mutation in a Chinese Diamond-Blackfan Anemia patient
por: Shi, Xiaodong, et al.
Publicado: (2019)

Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1
por: Osum, Sara H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ueunma8u5t3puhshm57t9e5edd